ACHL

Achilles Therapeutics (ACHL)

Achilles Therapeutics PLC

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ACHL

1 2 3 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/08	20:44	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ACHL	Achilles Therapeutics PLC
2024/05/08	20:00	GlobeNewswire Inc.	Achilles Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights	NASDAQ:ACHL	Achilles Therapeutics PLC
2024/04/04	19:45	GlobeNewswire Inc.	Achilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business Highlights	NASDAQ:ACHL	Achilles Therapeutics PLC
2024/04/04	19:30	GlobeNewswire Inc.	Achilles Therapeutics Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma Including First Patients Dosed with Enhanced Host Conditioning	NASDAQ:ACHL	Achilles Therapeutics PLC
2024/02/05	21:00	GlobeNewswire Inc.	Achilles Therapeutics to Present at the 10th Annual Immuno-Oncology 360 Conference	NASDAQ:ACHL	Achilles Therapeutics PLC
2024/02/02	03:14	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ACHL	Achilles Therapeutics PLC
2023/12/18	21:00	GlobeNewswire Inc.	Achilles Therapeutics Announces Publication of Nature Cancer ‘Comment’ on Strategy for Improved Neoantigen Immunogenicity Prediction	NASDAQ:ACHL	Achilles Therapeutics PLC
2023/11/14	06:36	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ACHL	Achilles Therapeutics PLC
2023/11/14	06:30	GlobeNewswire Inc.	Achilles Therapeutics Reports Third Quarter 2023 Financial Results and Recent Highlights	NASDAQ:ACHL	Achilles Therapeutics PLC
2023/11/02	06:26	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ACHL	Achilles Therapeutics PLC
2023/09/23	05:42	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ACHL	Achilles Therapeutics PLC
2023/09/23	05:30	GlobeNewswire Inc.	Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement	NASDAQ:ACHL	Achilles Therapeutics PLC
2023/09/20	21:45	InvestorsHub NewsWire	Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation	NASDAQ:ACHL	Achilles Therapeutics PLC
2023/08/18	04:16	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ACHL	Achilles Therapeutics PLC
2023/08/04	20:42	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ACHL	Achilles Therapeutics PLC
2023/08/04	20:00	GlobeNewswire Inc.	Achilles Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights	NASDAQ:ACHL	Achilles Therapeutics PLC
2023/06/30	05:04	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:ACHL	Achilles Therapeutics PLC
2023/06/30	05:03	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ACHL	Achilles Therapeutics PLC
2023/06/12	21:00	GlobeNewswire Inc.	Achilles Therapeutics to Present at Upcoming Conferences	NASDAQ:ACHL	Achilles Therapeutics PLC
2023/05/10	21:47	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:ACHL	Achilles Therapeutics PLC
2023/05/10	20:15	GlobeNewswire Inc.	Achilles Therapeutics Reports First Quarter 2023 Financial Results and Recent Business Highlights	NASDAQ:ACHL	Achilles Therapeutics PLC
2023/05/10	20:00	GlobeNewswire Inc.	Achilles Therapeutics’ New Immunogenicity Prediction Application of its AI-Powered PELEUS™ Platform Uniquely Identifies the Most Potent T Cell Antigens	NASDAQ:ACHL	Achilles Therapeutics PLC
2023/04/26	07:00	GlobeNewswire Inc.	Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement	NASDAQ:ACHL	Achilles Therapeutics PLC
2023/04/25	20:00	GlobeNewswire Inc.	Achilles Therapeutics Announces Grant of US Patent Covering the Treatment of Patients with an Immunotherapy Targeting Neoantigens Based on Tumor HLA Status	NASDAQ:ACHL	Achilles Therapeutics PLC
2023/04/17	21:00	GlobeNewswire Inc.	Achilles Therapeutics to Present at Chardan’s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit	NASDAQ:ACHL	Achilles Therapeutics PLC
2023/02/15	06:03	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ACHL	Achilles Therapeutics PLC
2023/02/15	06:02	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ACHL	Achilles Therapeutics PLC
2023/02/13	20:05	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ACHL	Achilles Therapeutics PLC
2022/12/31	06:58	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:ACHL	Achilles Therapeutics PLC
2022/12/24	07:16	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:ACHL	Achilles Therapeutics PLC